Find Scholarly Works

Search concepts
Selected Filters
2016
17 Citations (Scopus)

Reliability and validity of the Chronic Liver Disease Questionnaire (CLDQ) in adults with non-alcoholic steatohepatitis (NASH)

Chawla, K. S., Talwalkar, J. A., Keach, J. C., Malinchoc, M., Lindor, K. & Jorgensen, R., Dec 31 2016, In : BMJ Open Gastroenterology. 3, 1, e000069.

Research output: Contribution to journalArticle

Fatty Liver
Reproducibility of Results
Liver Diseases
Chronic Disease
Quality of Life
5 Citations (Scopus)

Shifting Paradigms: What Is the True Prevalence and Clinical Course of Primary Sclerosing Cholangitis?

Weersma, R. K. & Lindor, K., Oct 1 2016, In : Gastroenterology. 151, 4, p. 590-593 4 p.

Research output: Contribution to journalEditorial

Sclerosing Cholangitis
63 Citations (Scopus)

Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: A multicentre international study

Trivedi, P. J., Lammers, W. J., Van Buuren, H. R., Parés, A., Floreani, A., Janssen, H. L. A., Invernizzi, P., Battezzati, P. M., Ponsioen, C. Y., Corpechot, C., Poupon, R., Mayo, M. J., Burroughs, A. K., Nevens, F., Mason, A. L., Kowdley, K. V., Lleo, A., Caballeria, L., Lindor, K., Hansen, B. E. & 1 others, Hirschfield, G. M., Feb 1 2016, In : Gut. 65, 2, p. 321-329 9 p.

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Multicenter Studies
Hepatocellular Carcinoma
Kaplan-Meier Estimate
North America

Targets and investigative treatments for primary biliary cholangitis

Ali, A. H., Carey, E. J. & Lindor, K., Oct 2 2016, In : Expert Opinion on Orphan Drugs. 4, 10, p. 1011-1020 10 p.

Research output: Contribution to journalReview article

Cholangitis
Ursodeoxycholic Acid
Therapeutics
Phase III Clinical Trials
Phase II Clinical Trials
6 Citations (Scopus)

The management of autoimmunity in patients with cholestatic liver diseases

Ali, A. H., Carey, E. J. & Lindor, K., Jan 2 2016, (Accepted/In press) In : Expert Review of Gastroenterology and Hepatology.

Research output: Contribution to journalArticle

Autoimmunity
Liver Diseases
Autoimmune Diseases
Sclerosing Cholangitis
Cholangitis
5 Citations (Scopus)

The Microbiome and Primary Sclerosing Cholangitis

Ali, A. H., Carey, E. J. & Lindor, K., Sep 1 2016, In : Seminars in Liver Disease. 36, 4, p. 340-348 9 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Microbiota
End Stage Liver Disease
Probiotics
Ulcerative Colitis

Ursodeoxycholic acid treatment in primary sclerosing cholangitis

Tabibian, J. H. & Lindor, K., Jan 1 2016, Primary Sclerosing Cholangitis: Current Understanding, Management, and Future Developments. Springer International Publishing, p. 145-152 8 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ursodeoxycholic Acid
Sclerosing Cholangitis
Liver Diseases
Clinical Trials
Drug Therapy
42 Citations (Scopus)

Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof-of-concept study

PURIFI Study Group, Jul 1 2016, In : Hepatology. 64, 1, p. 189-199 11 p.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Cholangitis
Alkaline Phosphatase
Bile Acids and Salts
Liver Cirrhosis
2015
148 Citations (Scopus)

ACG clinical guideline: Primary sclerosing cholangitis

Lindor, K., Kowdley, K. V. & Harrison, M. E., May 8 2015, In : American Journal of Gastroenterology. 110, 5, p. 646-659 14 p.

Research output: Contribution to journalArticle

Bile Duct Neoplasms
Avitaminosis
Ursodeoxycholic Acid
Sclerosing Cholangitis
Metabolic Bone Diseases
43 Citations (Scopus)

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 1 2015, In : Journal of Hepatology. 63, 5, p. 1285-1287 3 p.

Research output: Contribution to journalArticle

Cholangitis
Biliary Liver Cirrhosis
Cholestasis
Terminology
Disease Progression
10 Citations (Scopus)

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 1 2015, In : Digestive and Liver Disease. 47, 11, p. 924-926 3 p., 2950.

Research output: Contribution to journalArticle

21st Century History
19th Century History
20th Century History
Cholangitis
Biliary Liver Cirrhosis
20 Citations (Scopus)

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 1 2015, In : Gut. 64, 11, p. 1671-1672 2 p.

Research output: Contribution to journalArticle

65 Citations (Scopus)

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 1 2015, In : Hepatology. 62, 5, p. 1620-1622 3 p.

Research output: Contribution to journalArticle

16 Citations (Scopus)

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Oct 1 2015, In : Clinics and Research in Hepatology and Gastroenterology. 39, 5, p. e57-e59 800.

Research output: Contribution to journalArticle

Cholangitis
Biliary Liver Cirrhosis
Terminology
Fibrosis
21 Citations (Scopus)

Changing nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 1 2015, In : American Journal of Gastroenterology. 110, 11, p. 1536-1538 3 p.

Research output: Contribution to journalArticle

Cholangitis
Biliary Liver Cirrhosis
Patient Preference
Terminology
Fibrosis
11 Citations (Scopus)

Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 1 2015, In : Clinical Gastroenterology and Hepatology. 13, 11, p. 1867-1869 3 p.

Research output: Contribution to journalArticle

Cholangitis
Biliary Liver Cirrhosis
Cholestasis
Terminology
Fibrosis
46 Citations (Scopus)

Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'

Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., Vierling, J. M. & Poupon, R., Nov 1 2015, In : Gastroenterology. 149, 6, p. 1627-1629 3 p.

Research output: Contribution to journalArticle

Cholangitis
Biliary Liver Cirrhosis
Cholestasis
Terminology
Fibrosis
24 Citations (Scopus)

Current research on the treatment of primary sclerosing cholangitis

Ali, A. H., Carey, E. J. & Lindor, K., 2015, In : Intractable and Rare Diseases Research. 4, 1, p. 1-6 6 p.

Research output: Contribution to journalShort survey

Sclerosing Cholangitis
Research
Therapeutics
Ulcerative Colitis
Liver Transplantation
126 Citations (Scopus)

Development and Validation of a Scoring System to Predict Outcomes of Patients with Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy

Lammers, W. J., Hirschfield, G. M., Corpechot, C., Nevens, F., Lindor, K., Janssen, H. L. A., Floreani, A., Ponsioen, C. Y., Mayo, M. J., Invernizzi, P., Battezzati, P. M., Parés, A., Burroughs, A. K., Mason, A. L., Kowdley, K. V., Kumagi, T., Harms, M. H., Trivedi, P. J., Poupon, R., Cheung, A. & 4 others, Lleo, A., Caballeria, L., Hansen, B. E. & Van Buuren, H. R., Dec 1 2015, In : Gastroenterology. 149, 7, p. 1804-1812e4

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Biliary Liver Cirrhosis
Paris
Survival
Therapeutics
6 Citations (Scopus)

Docetaxel Induced Sclerosing Cholangitis

Horsley-Silva, J. L., Dow, E. N., Menias, C. O., Smith, M. L., Carballido, E. M., Lindor, K. & Vargas, H. E., Dec 1 2015, In : Digestive Diseases and Sciences. 60, 12, p. 3814-3816 3 p.

Research output: Contribution to journalArticle

docetaxel
Tosyl Compounds
Propanolamines
Adrenergic alpha-1 Receptor Antagonists
Carbazoles
2 Citations (Scopus)

Editorial: Betaretrovirus in biliary epithelia of patients with autoimmune and cryptogenic liver disease

Tabibian, J. H. & Lindor, K., Mar 1 2015, In : Alimentary Pharmacology and Therapeutics. 41, 5, p. 490 1 p.

Research output: Contribution to journalArticle

Betaretrovirus
Autoimmune Hepatitis
Biliary Liver Cirrhosis
Liver Diseases
Hepatocytes
237 Citations (Scopus)

Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid

Hirschfield, G. M., Mason, A., Luketic, V., Lindor, K., Gordon, S. C., Mayo, M., Kowdley, K. V., Vincent, C., Bodhenheimer, H. C., Parés, A., Trauner, M., Marschall, H. U., Adorini, L., Sciacca, C., Beecher-Jones, T., Castelloe, E., Böhm, O. & Shapiro, D., Apr 1 2015, In : Gastroenterology. 148, 4, p. 751-761.e8

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Biliary Liver Cirrhosis
Placebos
Alkaline Phosphatase
gamma-Glutamyltransferase

Erratum: Primary biliary cirrhosis (Lancet (2015) 386 (1565-1575))

Carey, E. J., Ali, A. H. & Lindor, K., 2015, In : The Lancet. 386, 10003, p. 1536 1 p.

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
56 Citations (Scopus)

Novel therapeutic targets in primary biliary cirrhosis

Dyson, J. K., Hirschfield, G. M., Adams, D. H., Beuers, U., Mann, D. A., Lindor, K. & Jones, D. E. J., Mar 6 2015, In : Nature Reviews Gastroenterology and Hepatology. 12, 3, p. 147-158 12 p.

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Ursodeoxycholic Acid
Therapeutics
Fibrosis
Cholestasis

Orphan drugs in development for primary biliary cirrhosis: Challenges and progress

Ali, A. H., Byrne, T. J. & Lindor, K., 2015, In : Orphan Drugs: Research and Reviews. 5, p. 83-97 15 p.

Research output: Contribution to journalArticle

Orphan Drug Production
Biliary Liver Cirrhosis
Ursodeoxycholic Acid
Fibric Acids
Biochemistry
5 Citations (Scopus)

Primary biliary cirrhosis: Safety and benefits of established and emerging therapies

Tabibian, J. H. & Lindor, K., Sep 2 2015, In : Expert Opinion on Drug Safety. 14, 9, p. 1435-1444 10 p.

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Ursodeoxycholic Acid
Safety
Therapeutics
Pruritus
179 Citations (Scopus)

Primary biliary cirrhosis

Carey, E. J., Ali, A. H. & Lindor, K., Oct 17 2015, In : The Lancet. 386, 10003, p. 1565-1575 11 p.

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Ursodeoxycholic Acid
Fibrosis
Intrahepatic Bile Ducts
Antibodies
107 Citations (Scopus)

Recent advances in the development of farnesoid X receptor agonists

Ali, A. H., Carey, E. J. & Lindor, K., Jan 1 2015, In : Annals of Translational Medicine. 3, 1, 5.

Research output: Contribution to journalReview article

Bile Acids and Salts
Chenodeoxycholic Acid
Insulin Resistance
Biliary Liver Cirrhosis
Wounds and Injuries

Recurrence of primary sclerosing cholangitis after liver transplantation

Charatcharoenwitthaya, P. & Lindor, K., Jan 1 2015, Disease Recurrence After Liver Transplantation: Natural History, Treatment and Survival. Springer New York, p. 121-134 14 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Sclerosing Cholangitis
Liver Transplantation
Recurrence
Graft Survival
Fibrosis
37 Citations (Scopus)

Unmet clinical need in autoimmune liver diseases

Dyson, J. K., Webb, G., Hirschfield, G. M., Lohse, A., Beuers, U., Lindor, K. & Jones, D. E. J., Jan 1 2015, In : Journal of Hepatology. 62, 1, p. 208-218 11 p.

Research output: Contribution to journalArticle

Autoimmune Diseases
Liver Diseases
Therapeutics
Research
2014
2 Citations (Scopus)

An overview of current and future therapeutic strategies for the treatment of primary sclerosing cholangitis

Ali, A. H., Carey, E. J. & Lindor, K., 2014, In : Expert Opinion on Orphan Drugs. 2, 6, p. 545-556 12 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Ursodeoxycholic Acid
Therapeutics
Biliary Liver Cirrhosis
Expert Testimony
8 Citations (Scopus)

Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis

Tabibian, J. H., Enders, F., Imam, M. H., Kolar, G., Lindor, K. & Talwalkar, J. A., 2014, In : Annals of Hepatology. 13, 3, p. 384-389 6 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Immunoglobulin E
Cholangiocarcinoma
Serum
Survival

Association of adiposity, measures of metabolic dysregulation, and elevated alanine aminotransferase in subjects with normal body mass index

Treeprasertsuk, S., Romero-Corral, A., Somers, V. K., Sierra-Johnson, J., Lindor, K., Angulo, P. & Lopez-Jimenez, F., Oct 1 2014, In : Asian Biomedicine. 8, 5, p. 585-595 11 p.

Research output: Contribution to journalArticle

Adiposity
Alanine Transaminase
Body Mass Index
Waist Circumference
Fats
171 Citations (Scopus)

Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis

Musso, G., Gambino, R., Tabibian, J. H., Ekstedt, M., Kechagias, S., Hamaguchi, M., Hultcrantz, R., Hagström, H., Yoon, S. K., Charatcharoenwitthaya, P., George, J., Barrera, F., Haflidadóttir, S., Björnsson, E. S., Armstrong, M. J., Hopkins, L. J., Gao, X., Francque, S., Verrijken, A., Yilmaz, Y. & 13 others, Lindor, K., Charlton, M., Haring, R., Lerch, M. M., Rettig, R., Völzke, H., Ryu, S., Li, G., Wong, L. L., Machado, M., Cortez-Pinto, H., Yasui, K. & Cassader, M., 2014, In : PLoS Medicine. 11, 7, e1001680.

Research output: Contribution to journalArticle

Chronic Renal Insufficiency
Meta-Analysis
Odds Ratio
Biochemistry
Histology

Clinical spectrum and management

Björnsson, E. S. & Lindor, K., Feb 1 2014, Autoimmune (IgG4-Related) Pancreatitis and Cholangitis. Springer New York, p. 171-179 9 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Immunoglobulin G
Sclerosing Cholangitis
Pathologic Constriction
Steroids
Retroperitoneal Fibrosis
5 Citations (Scopus)

Diagnosis and management of primary biliary cirrhosis

Ali, A. H., Carey, E. J. & Lindor, K., Dec 1 2014, In : Expert Review of Clinical Immunology. 10, 12, p. 1667-1678 12 p.

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Ursodeoxycholic Acid
Liver Transplantation
Intrahepatic Bile Ducts
Antibodies

Foreword

Lindor, K., Jan 1 2014, In : Unknown Journal. p. vii-viii

Research output: Contribution to journalArticle

5 Citations (Scopus)

Hepatocellular carcinoma: Low risk of HCC in patients who have PSC and cirrhosis

Gossard, A. A. & Lindor, K., 2014, In : Nature Reviews Gastroenterology and Hepatology. 11, 5, p. 276-277 2 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Liver Neoplasms
Liver Cirrhosis
Hepatocellular Carcinoma
Fibrosis
149 Citations (Scopus)

Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: An international follow-up study

Global PBC Study Group, Dec 1 2014, In : Gastroenterology. 147, 6, p. 1338-1349.e5

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Bilirubin
Alkaline Phosphatase
Biomarkers
Liver Transplantation
1 Citation (Scopus)

Magic wand and crystal ball for primary sclerosing cholangitis

Vuppalanchi, R. & Lindor, K., 2014, In : Gastroenterology. 146, 4, p. 890-892 3 p.

Research output: Contribution to journalArticle

Elasticity Imaging Techniques
Sclerosing Cholangitis
Magic
Liver Cirrhosis
Liver
12 Citations (Scopus)

Neoplasia in the ileoanal pouch following colectomy in patients with ulcerative colitis and primary sclerosing cholangitis

Imam, M. H., Eaton, J. E., Puckett, J. S., Loftus, E. V., Mathis, K. L., Gossard, A. A., Talwalkar, J. A. & Lindor, K., Oct 1 2014, In : Journal of Crohn's and Colitis. 8, 10, p. 1294-1299 6 p.

Research output: Contribution to journalArticle

Colonic Pouches
Sclerosing Cholangitis
Colectomy
Ulcerative Colitis
Inflammatory Bowel Diseases
29 Citations (Scopus)

Obeticholic acid and budesonide for the treatment of primary biliary cirrhosis

Silveira, M. G. & Lindor, K., Feb 2014, In : Expert Opinion on Pharmacotherapy. 15, 3, p. 365-372 8 p.

Research output: Contribution to journalArticle

Budesonide
Biliary Liver Cirrhosis
Bile Acids and Salts
Liver Diseases
Ursodeoxycholic Acid
17 Citations (Scopus)

Primary biliary cirrhosis in adults

Momah, N. & Lindor, K., 2014, In : Expert Review of Gastroenterology and Hepatology. 8, 4, p. 427-433 7 p.

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Ursodeoxycholic Acid
Cholestasis
Liver Cirrhosis
Liver Diseases
41 Citations (Scopus)

Primary sclerosing cholangitis and the microbiota: Current knowledge and perspectives on etiopathogenesis and emerging therapies

Tabibian, J. H., O'Hara, S. P. & Lindor, K., 2014, In : Scandinavian Journal of Gastroenterology. 49, 8, p. 901-908 8 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Microbiota
Inflammatory Bowel Diseases
Therapeutics
Enterohepatic Circulation
20 Citations (Scopus)

Prospective clinical trial of rifaximin therapy for patients with primary sclerosing cholangitis

Tabibian, J. H., Gossard, A., El-Youssef, M., Eaton, J. E., Petz, J., Jorgensen, R., Enders, F. B., Tabibian, A. & Lindor, K., Jun 9 2014, (Accepted/In press) In : American Journal of Therapeutics.

Research output: Contribution to journalArticle

rifaximin
Sclerosing Cholangitis
Clinical Trials
Alkaline Phosphatase
Liver Diseases
23 Citations (Scopus)

The natural history of primary biliary cirrhosis

Imam, M. H. & Lindor, K., 2014, In : Seminars in Liver Disease. 34, 3, p. 329-333 5 p.

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Ursodeoxycholic Acid
Touch
Early Diagnosis
22 Citations (Scopus)

Ursodeoxycholic acid in primary sclerosing cholangitis: If withdrawal is bad, then administration is good (right?)

Tabibian, J. H. & Lindor, K., 2014, In : Hepatology. 60, 3, p. 785-788 4 p.

Research output: Contribution to journalArticle

Cholagogues and Choleretics
Ursodeoxycholic Acid
Sclerosing Cholangitis
Bile Acids and Salts
2013
4 Citations (Scopus)

An update on primary sclerosing cholangitis: From pathogenesis to treatment

Imam, M. H., Talwalkar, J. A. & Lindor, K., Mar 2013, In : Minerva Gastroenterologica e Dietologica. 59, 1, p. 49-58 10 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Cholangiography
Causality
Biomedical Research
Liver Diseases
12 Citations (Scopus)

Clinical management of autoimmune biliary diseases

Imam, M. H., Talwalkar, J. A. & Lindor, K., Oct 2013, In : Journal of Autoimmunity. 46, p. 88-96 9 p.

Research output: Contribution to journalArticle

Autoimmune Diseases
Sclerosing Cholangitis
Biliary Liver Cirrhosis
Ursodeoxycholic Acid
Autoimmune Hepatitis
9 Citations (Scopus)

Colonic neoplasia in young patients with inflammatory bowel disease and primary sclerosing cholangitis

Imam, M. H., Thackeray, E. W. & Lindor, K., Feb 2013, In : Colorectal Disease. 15, 2, p. 198-203 6 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Inflammatory Bowel Diseases
Neoplasms
Colonoscopy
Colonic Neoplasms